These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6544115)

  • 21. Enhanced DNA excision repair in CCRF-CEM cells resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea, quantitated using the single cell gel electrophoresis (Comet) assay.
    Yamauchi T; Kawai Y; Ueda T
    Biochem Pharmacol; 2003 Sep; 66(6):939-46. PubMed ID: 12963480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the inhibition of glutathione reductase and the recovery of enzyme activity in exponentially growing murine leukemia (L1210) cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Cohen MB; Duvel DL
    Biochem Pharmacol; 1988 Sep; 37(17):3317-20. PubMed ID: 3401259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
    Rice KP; Penketh PG; Shyam K; Sartorelli AC
    Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical mechanisms of resistance to a new antineoplastic drug CRC 680578 from the nitrosourea class].
    Gudtsova KV; Kukushkina GV; Gorbacheva LB
    Biokhimiia; 1991 Aug; 56(8):1509-21. PubMed ID: 1782268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells.
    Seidenfeld J; Barnes D; Block AL; Erickson LC
    Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma.
    Dinapoli RP; Brown LD; Arusell RM; Earle JD; O'Fallon JR; Buckner JC; Scheithauer BW; Krook JE; Tschetter LK; Maier JA
    J Clin Oncol; 1993 Jul; 11(7):1316-21. PubMed ID: 8315428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro chemosensitivity testing of Fotemustine (S 10036), a new antitumor nitrosourea.
    Fischel JL; Formento P; Etienne MC; Gioanni J; Frenay M; Deloffre P; Bizzari JP; Milano G
    Cancer Chemother Pharmacol; 1990; 25(5):337-41. PubMed ID: 2306793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of intracarotid PCNU.
    Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
    J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
    Oguro M; Yanagawa T; Takenaga K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2550-6. PubMed ID: 6594974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relation between the changes in the structure and synthesis of DNA in the cells of mouse leukemia L1210 induced by 1-methyl-1-nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea].
    Durdyeva ED; Kukushkina GV; Gorbacheva KB
    Biull Eksp Biol Med; 1986 Feb; 101(2):192-5. PubMed ID: 3947737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antineoplastic agents. 1. Synthesis and antineoplastic activities of chloroethyl- and methylnitrosourea analogues of thymidine.
    Lin TS; Fischer PH; Shiau GT; Prusoff WH
    J Med Chem; 1978 Jan; 21(1):130-3. PubMed ID: 563461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracarotid infusion of PCNU (NSC: 95466): preclinical toxicological study in dogs.
    Goumnerova L; Richard MT; Addison D; Montpetit V; Stewart DJ
    J Neurooncol; 1987; 5(3):205-9. PubMed ID: 3681384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
    Finch RA; Shyam K; Penketh PG; Sartorelli AC
    Cancer Res; 2001 Apr; 61(7):3033-8. PubMed ID: 11306484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.
    Ewig RA; Kohn KW
    Cancer Res; 1978 Oct; 38(10):3197-203. PubMed ID: 150940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rejection of reovirus-treated L1210 leukemia cells by mice.
    Williams ME; Cox DC; Stevenson JR
    Cancer Immunol Immunother; 1986; 23(2):87-92. PubMed ID: 2946408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor effect of 1,1'-polymethylene-bis (1-nitrosourea) and related compounds.
    Miyahara M; Nakadate M; Miyahara M; Suzuki I; Ishidate M; Odashima S
    Gan; 1977 Oct; 68(5):573-80. PubMed ID: 201535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of 1,3-bis(2-chloroethyl)-1-nitrosourea-induced cytotoxicity and DNA damage by alpha-difluoromethylornithine in L1210 leukemia cells.
    Cavanaugh PF; Pavelic ZP; Porter CW
    Cancer Res; 1984 Sep; 44(9):3856-61. PubMed ID: 6430555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PCNU and recurrent childhood brain tumors.
    Allen JC; Hancock C; Walker R; Tan C
    J Neurooncol; 1987; 5(3):241-4. PubMed ID: 3681386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.